Foley Hoag advised Applied Genetic Technologies Corporation (“AGTC”) on the deal. Applied Genetic Technologies Corporation (Nasdaq: AGTC) (“AGTC”), a clinical-stage biotechnology company focused on the development...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP represented The Valens Company on the deal. The Valens Company (TSX: VLNS; Nasdaq: VLNS), a leading manufacturer of cannabis products, announced its underwritten “bought...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised Trulieve Cannabis Corp. on the deal. Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) annunced its marketed public offering of 5,000,000 subordinate voting shares...
You must be a Standard 1 Year member to access this content.
